To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.
Collaboration

Patient-Focused Drug Development: A Systematic Approach

Patient Focused Drug Development A Systematic Approach Feature Image

If you’ve been following us for a while, you may have noticed that our blog and Twitter content often points out that clinical research involves a partnership among many groups of people: sponsor companies (such as Lilly), study coordinators and principal investigators at clinical research sites, ethical review boards, and, of course, patients. The image we created on Lilly TrialGuide to illustrate the relationship among these various groups is meant to subtly show that the patient is at the center of clinical research. Who is involved in clinical trials

While health care providers may be experts on the clinical aspects of a given medical condition, patients are experts on what it is like to live with their condition. When we are developing a potential new treatment in a specific disease, we need to understand several key points:

  • What does it mean to the patient to have this disease or condition?
  • What do patients experience with this disease or condition?
  • What would a successful treatment look like from the patient’s perspective?

Patients have a unique viewpoint that can provide insights on the outcomes that matter most to them.

  • Severity and frequency of symptoms
  • Impact on daily function and daily life

PROAdapted Bullets 17Apr2019-01

This approach is aligned with upcoming guidance from the U.S. FDA on Patient-Focused Drug Development, or PFDD. PFDD is a systematic approach to help ensure that patients’ experiences, perspectives, needs, and priorities are captured and meaningfully incorporated into the development and evaluation of medical products, at all stages along the way.

For example, we often use patient questionnaires in our clinical research studies to collect information from the patient’s perspective. These patient questionnaires are one form of patient-reported outcomes, or PROs. A PRO is defined as “any report of the status of a patient’s health condition that comes directly from the patient, without interpretation of the patient’s response by a clinician or anyone else." Understanding the patient’s viewpoint through measures like PROs can be just as important as data we collect through things like laboratory samples (such as blood, urine, stool, or tissue) and imaging results (such as CT, MRI, or PET scans).

Patients are experts on what it is like to live with their condition, and we are making it a priority to listen to them. Drug development is at its best when we include the patient perspective throughout the process.

Tags: PROs,

Recent Articles

Magnifying glass looking over a piece of paper

Clinical Trial History: Being Transparent in Research

Leigh Anne Naas Headshot
Leigh Anne Naas
October 16th, 20192 minute read

In the long-evolving process of clinical research, the most recent focus is transparency. Explore more in this infographic.

Rik standing next to his mom Anu at conference

Following Your Dreams with IBD: Tips from the Experts

Susan Gilchrist Headshot
Susan Gilchrist
September 16th, 20194 minute read

Read tips from a patient and caregiver expert for how to achieve your dreams while managing a chronic disease like IBD.

Chalkboard graphic

Chalking Up Components of Clinical Research

Leigh Anne Naas Headshot
Leigh Anne Naas
August 19th, 20192 minute read

In clinical research, who needs to know what, and when and how do they get that information? Check out our overview.

melissas-hope-featured-image

Melissa's Hope

LTGBlogAuthors GuestAuthorIcon 20July2018
Guest Author
August 5th, 20194 minute read

In part two of this two-part guest blog series, Brendan shares the experience he and his wife Melissa had as clinical trial participants.

Clinical Trial Design Across the Ages

Clinical Trial History: Clinical Trial Design Across the Ages

Leigh Anne Naas Headshot
Leigh Anne Naas
August 2nd, 20192 minute read

Clinical trials have evolved over the millennia to be more complex and more specific in the goals and outcomes they measure.